Jasper Therapeutics (JSPR) Current Taxes (2019 - 2020)

Jasper Therapeutics (JSPR) posted quarterly Current Taxes of $7913.0 for Q3 2020, down 89.14% quarter-over-quarter from $72853.0 in Q2 2020.

Jasper Therapeutics (JSPR) Current Taxes (2019 - 2020) Analysis & Trends

Jasper Therapeutics' Current Taxes history runs 2 years deep, the most recent figure standing at $7913.0 for Q3 2020.

In Q3 2020, Current Taxes changed N/A year-over-year to $7913.0; the TTM figure through Sep 2020 stood at $7913.0 (changed N/A YoY), while the FY2019 annual figure was $16225.0, changed N/A from the prior year.
Current Taxes for Q3 2020 stood at $7913.0, down from $72853.0 in the prior quarter.
The five-year high for Current Taxes was $74048.0 in Q1 2020, with the low at $7913.0 in Q3 2020.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Current Taxes (Qtr)
1	Vertex Pharmaceuticals	137.11 Bn	129.26 Bn	2.84 Bn	-
2	Regeneron Pharmaceuticals	84.98 Bn	76.99 Bn	3.93 Bn	-
3	Argenx Se	64.52 Bn	59.33 Bn	1.37 Bn	49.00 Mn
4	Moderna	53.23 Bn	48.09 Bn	52.00 Mn	-
5	BeOne Medicines	41.23 Bn	36.14 Bn	1.53 Bn	76.32 Mn
6	Alnylam Pharmaceuticals	30.65 Bn	27.34 Bn	992.69 Mn	-
7	Insmed	27.15 Bn	25.99 Bn	358.27 Mn	-
8	Royalty Pharma	26.98 Bn	26.14 Bn	-	-
9	BioNTech SE	26.78 Bn	8.39 Bn	668.28 Mn	76.36 Mn
10	Jasper Therapeutics	20.06 Mn	20.06 Mn	-	-

Download Data